Antitargets and Drug Safety

Discover the essential resource for drug developers in "Antitargets and Drug Safety" by Laszlo Urban, published by Wiley-VCH Verlag GmbH in 2015. This comprehensive hardback spans 528 pages, providing an in-depth examination of antitarget-related side effects, including hepatic, cardiovascular, kinase, and GPCR-mediated toxicity. The book not only highlights the most common challenges faced in drug development but also offers current strategies to effectively manage these side effects. Enhanced with several insightful case studies, this practical reference is an invaluable tool for professionals seeking to navigate the complexities of drug safety. Equip yourself with the knowledge to enhance drug efficacy while minimizing risks—order your copy today!